Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Neutral

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

ChromaDex Corporation (CDXC)

Medicinal Chemicals & Botanical Products

https://www.chromadex.com

ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segment namely Consumer Products, Ingredients segment and Analytical Reference Standards and Services. Majority of the revenue is earned from Consumer Products segment.

10900 WILSHIRE BLVD, SUITE 600
LOS ANGELES, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/24/2008

Market Cap

249,060,568

Shares Outstanding

75,120,000

Weighted SO

75,124,418

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

IKNA --.--%

ENOB --.--%

ELYM --.--%

HCWB --.--%

XCUR --.--%

IPSC --.--%

KZR --.--%

MLYS --.--%

NKTX --.--%

Beta

1.8730

Last Div

0.0000

Range

1.25-4.65

Chg

-0.0150

Avg Vol

399846

Mkt Cap

249060568

Exch

NASDAQ

Country

US

Phone

310 388 6706

DCF Diff

7.1489

DCF

-3.5589

Div Yield

0.0000

P/S

2.9102

EV Multiple

175.3710

P/FV

8.0680

Div Yield %

0.0000

P/E

-183.3088

PEG

-11.3426

Payout

0.0000

Current Ratio

2.7594

Quick Ratio

2.1151

Cash Ratio

1.5607

DSO

33.3427

DIO

125.3136

Op Cycle

158.6563

DPO

88.2345

CCC

70.4219

Gross Margin

0.6082

Op Margin

-0.0035

Pretax Margin

-0.0158

Net Margin

-0.0158

Eff Tax Rate

-1.0402

ROA

-0.0250

ROE

-0.0468

ROCE

-0.0083

NI/EBT

1.0000

EBT/EBIT

4.4768

EBIT/Rev

-0.0035

Debt Ratio

0.0578

D/E

0.1017

LT Debt/Cap

0.0651

Total Debt/Cap

0.0923

Int Coverage

1.5812

CF/Debt

0.3169

Equity Multi

1.7591

Rec Turnover

10.9469

Pay Turnover

4.1367

Inv Turnover

2.9127

FA Turnover

21.9219

Asset Turnover

1.5838

OCF/Share

0.0131

FCF/Share

0.0118

Cash/Share

0.3690

OCF/Sales

0.0116

FCF/OCF

0.8990

CF Coverage

0.3169

ST Coverage

1.0051

CapEx Coverage

9.9000

Div&CapEx Cov

9.9000

P/BV

8.0680

P/B

8.0680

P/S

2.9102

P/E

-183.3088

P/FCF

279.8433

P/OCF

250.3369

P/CF

250.3369

PEG

-11.3426

P/S

2.9102

EV Multiple

175.3710

P/FV

8.0680

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation